Key result
In patients with perioperative myocardial infarction after CABG, re-CABG resulted in a lower 3-year MACE rate (13.2%) compared to conservative therapy (34%) and PCI (36%) (p=0.05).
Why the study?
Does PCI or re-CABG improve outcomes compared to conservative therapy in patients with perioperative myocardial infarction after CABG?
Cohort (n=113)
Does PCI or re-CABG improve outcomes compared to conservative therapy in patients with perioperative myocardial infarction after CABG?
Absolute Event Rate: 13.2% vs 34%
p-value: p=0.05
In patients with perioperative MI after CABG, re-CABG is associated with lower rates of MACE and better angina relief at 3 years compared to PCI or conservative therapy, although survival rates are similar.
Re-CABG was associated with lower MACE; leaves open optimal strategy and should not yet change practice pending randomized trials.
BACKGROUND: The purpose of the study was to analyze the causes of postoperative myocardial infarction (PMI) and the impact of different treatment strategies on (1) postoperative outcome, (2) major adverse events (MACE), and (3) postoperative Canadian Cardiovascular Society (CCS) at 3-year follow-up. PATIENTS: Between May 2001 and July 2006, 113 patients with PMI were categorized in three groups: (A) conservative therapy (50 patients); (B) percutaneous coronary intervention (PCI) (25 patients), and (C) re-CABG (38 patients). RESULTS: Overall in-hospital mortality was 7.1% (n = 8), being 10.0% in group A (n = 5), 4.0% in group B (n = 1) and 5.3% (n = 2) in group C (p = n.s.), respectively. The cumulative survival rates at 3 years were 90% for group A, 92% for group B, and 89.5% for group C (p = n.s). The MACE rate at 3-year follow-up for all patients was 27.4% and was significantly higher in group A (34%) and group B (36%) compared with group C (13.2%) (p = 0.05). Mean CCS was significantly reduced at follow-up in the groups compared with the preoperative angina class. However, group B and C showed a significant improvement in CCS compared with group A (p = 0.044/p < 0.001). Further group C was superior to group B (p = 0.032). CONCLUSION: At 3 years of follow-up, this study showed no survival benefits from any therapeutical procedure; however patients treated with re-CABG had better freedom from repeat revascularization procedures and from MACCE. In addition, the conservative and PCI group had a higher incidence of recurrence of angina.
No takes yet. Share an insight, caveat, or question.
Alexiou et al. (2012) conducted a cohort in Perioperative myocardial infarction after coronary artery bypass surgery (n=113). re-CABG vs. Conservative therapy was evaluated on Major adverse events (MACE) at 3-year follow-up (p=0.05). In patients with perioperative myocardial infarction after CABG, re-CABG resulted in a lower 3-year MACE rate (13.2%) compared to conservative therapy (34%) and PCI (36%) (p=0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: